These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17530945)

  • 21. [Use of anabolic androgenic steroids, growth hormone and erythropoietin by patients in general practice].
    Keld DB; Hahn T
    Ugeskr Laeger; 2006 Sep; 168(37):3121-4. PubMed ID: 16999915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggression and body image concerns among anabolic androgenic steroid users, contemplators, and controls in Norway.
    Jenssen IH; Johannessen KB
    Body Image; 2015 Jan; 12():6-13. PubMed ID: 25261635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The aetiology and trajectory of anabolic-androgenic steroid use initiation: a systematic review and synthesis of qualitative research.
    Sagoe D; Andreassen CS; Pallesen S
    Subst Abuse Treat Prev Policy; 2014 Jul; 9():27. PubMed ID: 24984881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growing trends in the pursuit of muscularity: what healthcare professionals should be aware of.
    Kowalski C; Leonard O
    Br J Gen Pract; 2015 Dec; 65(641):626-7. PubMed ID: 26622012
    [No Abstract]   [Full Text] [Related]  

  • 25. Desire for weight gain and potential risks of adolescent males using anabolic steroids.
    Wang MQ; Yesalis CE; Fitzhugh EC; Buckley WE
    Percept Mot Skills; 1994 Feb; 78(1):267-74. PubMed ID: 8177669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anabolic steroid users' attitudes towards physicians.
    Pope HG; Kanayama G; Ionescu-Pioggia M; Hudson JI
    Addiction; 2004 Sep; 99(9):1189-94. PubMed ID: 15317640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimated prevalence of anabolic steroid use among male high school seniors.
    Buckley WE; Yesalis CE; Friedl KE; Anderson WA; Streit AL; Wright JE
    JAMA; 1988 Dec; 260(23):3441-5. PubMed ID: 3210283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying a typology of men who use anabolic androgenic steroids (AAS).
    Zahnow R; McVeigh J; Bates G; Hope V; Kean J; Campbell J; Smith J
    Int J Drug Policy; 2018 May; 55():105-112. PubMed ID: 29525360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for anabolic-androgenic steroid use in men.
    Brower KJ; Blow FC; Hill EM
    J Psychiatr Res; 1994; 28(4):369-80. PubMed ID: 7877116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated anabolic androgenic steroid treatment causes antidepressant-reversible alterations of the hypothalamic-pituitary-adrenal axis, BDNF levels and behavior.
    Matrisciano F; Modafferi AM; Togna GI; Barone Y; Pinna G; Nicoletti F; Scaccianoce S
    Neuropharmacology; 2010 Jun; 58(7):1078-84. PubMed ID: 20138062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting drive for muscularity behavioural engagement from body image attitudes and emotions.
    Tod D; Edwards C
    Body Image; 2013 Jan; 10(1):135-8. PubMed ID: 23021637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
    Razavi Z; Moeini B; Shafiei Y; Bazmamoun H
    J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program.
    Goldberg L; Elliot D; Clarke GN; MacKinnon DP; Moe E; Zoref L; Green C; Wolf SL; Greffrath E; Miller DJ; Lapin A
    JAMA; 1996 Nov; 276(19):1555-62. PubMed ID: 8918852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experiences of anabolic steroid use: in-depth interviews with men and women body builders.
    Grogan S; Shepherd S; Evans R; Wright S; Hunter G
    J Health Psychol; 2006 Nov; 11(6):845-56. PubMed ID: 17035257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anabolic steroid induced hypogonadism in young men.
    Coward RM; Rajanahally S; Kovac JR; Smith RP; Pastuszak AW; Lipshultz LI
    J Urol; 2013 Dec; 190(6):2200-5. PubMed ID: 23764075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A psychological perspective on male rejuvenation.
    Miner MM; Perelman MA
    Fertil Steril; 2013 Jun; 99(7):1803-6. PubMed ID: 23726253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cultural perceptions of healthy weight in rural Appalachian youth.
    Williams KJ; Taylor CA; Wolf KN; Lawson RF; Crespo R
    Rural Remote Health; 2008; 8(2):932. PubMed ID: 18503293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Illicit use and abuse of anabolic-androgenic steroids among Brazilian bodybuilders.
    Santos AM; da Rocha MS; da Silva MF
    Subst Use Misuse; 2011; 46(6):742-8. PubMed ID: 21114402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caution for anabolic androgenic steroid use: a case report of multiple organ dysfunction syndrome.
    Unai S; Miessau J; Karbowski P; Baram M; Cavarocchi NC; Hirose H
    Respir Care; 2013 Dec; 58(12):e159-63. PubMed ID: 23611866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anabolic-androgenic steroids and heroin use: a qualitative study exploring the connection.
    Cornford CS; Kean J; Nash A
    Int J Drug Policy; 2014 Sep; 25(5):928-30. PubMed ID: 25008191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.